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Background: Clinical outcomes of coronavirus disease 2019 (COVID-19), caused
by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) showed
enormous inter-individual and inter-population differences, possibly due to host genetics
differences. Earlier studies identified single nucleotide polymorphisms (SNPs) associated
with SARS-CoV-1 in Eastern Asian (EAS) populations. In this report, we aimed at
exploring the frequency of a set of genetic polymorphisms that could affect SARS-
CoV-2 susceptibility or severity, including those that were previously associated with
SARS-CoV-1.
Methods: We extracted the list of SNPs that could potentially modulate SARS-CoV-
2 from the genome wide association studies (GWAS) on SARS-CoV-1 and other
viruses. We also collected the expression data of these SNPs from the expression
quantitative trait loci (eQTLs) databases. Sequences from Qatar Genome Programme
(QGP, n = 6,054) and 1000Genome project were used to calculate and compare allelic
frequencies (AF).
Results: A total of 74 SNPs, located in 10 genes: ICAM3, IFN-γ, CCL2, CCL5,
AHSG, MBL, Furin, TMPRSS2, IL4, and CD209 promoter, were identified. Analysis of
Qatari genomes revealed significantly lower AF of risk variants linked to SARS-CoV-1
severity (CCL2, MBL, CCL5, AHSG, and IL4) compared to that of 1000Genome and/or
the EAS population (up to 25-fold change). Conversely, SNPs in TMPRSS2, IFN-γ,
ICAM3, and Furin were more common among Qataris (average 2-fold change). Inter-
population analysis showed that the distribution of risk alleles among Europeans differs
substantially from Africans and EASs. Remarkably, Africans seem to carry extremely
lower frequencies of SARS-CoV-1 susceptibility alleles, reaching to 32-fold decrease
compared to other populations.
Conclusion: Multiple genetic variants, which could potentially modulate SARS-CoV-
2 infection, are significantly variable between populations, with the lowest frequency
observed among Africans. Our results highlight the importance of exploring population
genetics to understand and predict COVID-19 outcomes. Indeed, further studies are
needed to validate these findings as well as to identify new genetic determinants
linked to SARS-CoV-2.
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INTRODUCTION
Viruses have been replicating in vertebrates for more than
450 million years (Aiewsakun and Katzourakis, 2017).
This host-pathogen interaction has exerted a selective
pressure over time and affected specific allelic frequencies
of certain populations to favor a particular genetic variant.
The frequent outbreaks of coronaviruses in China (SARS-
CoV-1 in 2003, and the current SARS-CoV-2) raised the
possibility that Asians have unique genetic factors that
influence their susceptibility to coronaviruses (Chen et al.,
2020). In addition, the large variation in coronavirus disease
2019 (COVID-19) clinical manifestation has raised multiple
questions on the underlying factors, including host genetics.
Moreover, COVID-19 mortality rates were considerably
variable between different regions, ranging from 0.06%
(Singapore) to 15% (the United Kingdom) (Statistica, 2020).
Interestingly, although Qatar has the world’s highest COVID-
19 infection rate per million people (38,714 cases/million),
it is one of the countries reporting the lowest severity
(1% ICU cases) and mortality rates (0.16%) (Our World
in Data, 2020). Although age, health condition, disease
management, and health systems contribute to different
disease outcomes, there is a strong indication that vulnerability
to COVID-19 is influenced by host genetic architecture
(Tanigawa and Rivas, 2020).
In an effort to explore the susceptibility to SARS-CoV-
1 in Chinese populations, multiple GWASs were conducted.
Despite the limitation in the number of SARS-CoV-1 infected
individuals, few reports identified significant associations. For
instance, a variant (rs2248690) in the α-2-Heremans-Schmid
Glycoprotein (AHSG) gene, which is required for macrophage
deactivation, was found to affect AHSG level in the blood
(Zhu et al., 2011). Carriers of the T allele had lower AHSG
serum concentration and increased risk of SARS illness (Zhu
et al., 2011). Low levels of the Mannose-binding lectin (MBL),
another key molecule in innate immunity, caused by a missense
variant (rs1800450), was also linked to increased SARS-CoV-
1 susceptibility (Tu et al., 2015). Similarly, a functional
polymorphism of the chemokine (C–C motif) ligand 2 (CCL2)
gene (rs1024611) was associated with an increased risk of
SARS-CoV-1 infection (Tu et al., 2015). CCL2 belongs to the
chemokines family, and plays a vital role in immune cells
trafficking during SARS-CoV-1 infection (Law et al., 2005).
In addition, a variant (rs2280788) within another chemokine
encoding gene, CCL5, has been found to associate with SARS
susceptibility, hospitalization, and risk of death (Ng et al.,
2007). Other variants in cytokines encoding genes have also
been linked to SARS outcomes. Specifically, a polymorphism
in the interferon (IFN)-γ gene (rs2430561, A), which is
essential in driving T helper cell type 1 (Th1), monocytes, and
macrophages responses, showed a dose-dependent increase in
the susceptibility to SARS-CoV-1 (Chong et al., 2006). IL4,
on the other hand, promotes and stimulates both T-cell and
B-cell differentiation, and balances Th1 and Th2 responses,
therefore, directly affects infection outcomes (Choi and Reiser,
1998). A meta-analysis by Patarčić et al. (2015) reported on
the association of interleukin 4 (IL4) polymorphism (rs2070874)
and multiple respiratory infections, including SARS-CoV-1.
Another key T-cell activation molecule is the intercellular
adhesion molecule-3 (ICAM3). SARS-CoV-1 patients carrying a
genetic polymorphism in the ICAM3 gene (rs2304237) showed
higher lactate dehydrogenase (LDH) level, lower WBC count,
and thus, poorer prognosis (Chan et al., 2007). Similarly,
a SNP (rs4804803) located in the CD209, or the dendritic
cell–specific ICAM-3–grabbing nonintegrin (DC-SIGN) gene
promoter, was associated with high LDH levels in SARS-CoV-1
patients (Chan et al., 2010). This gene encodes for an important
C-type lectin that acts as a pathogen receptor. Previous studies
demonstrated that CD209 interacts with the spike (S)–protein
of SARS-CoV-1 and enhances spike (S)-pseudotyped SARS-
CoV-1 infection in susceptible cells (Marzi et al., 2004). It
was found that SARS-CoV-1 patients who carry -336A > G
variant have a 60% chance of having a poorer prognosis
(Chan et al., 2010).
Recent studies indicated that SARS-CoV-2 spread depends
on the transmembrane serine protease 2 (TMPRSS2) for
virus entry (Hoffmann et al., 2020b). Importantly, SARS-CoV-
2 is characterized by the acquisition of a S1/S2 multibasic
cleavage site, and therefore, other proteases, including Furin
and cathepsin B/L could substitute TMPRSS2 (Hoffmann
et al., 2020a,b). Considering that influenza virus entry also
utilizes TMPRSS2 for the cleavage of viral hemagglutinin
(HA) protein, the genetic association of TMPRSS2 variants
and influenza infection was previously investigated. Variants
within TMPRSS2 (rs2070788, rs383510) were found to increase
TMPRSS2 expression and significantly correlate with influenza
A(H1N1)pdm09 and A(H7N9) susceptibility and severity (Cheng
et al., 2015). On the other hand, there was no GWAS on
the association between cathepsin B/L (CTSB/CTSL) variants
and viral infections, and only one GWAS identified a variant
(rs4932178, T) in Furin promoter that was linked to Furin
upregulation in hepatitis B patients (Lei et al., 2009). Given the
similarity between the novel SARS-CoV-2 and SARS-CoV-1, as
well as the involvement of different proteases in the SARS-CoV-2
pathogenesis, this study investigates and compares the frequency




The present study included a subpopulation (n = 6,218)
from a cohort of 10,694 participants in Qatar Biobank.
A detailed demographic characterization of this cohort has
been previously documented (Al Thani et al., 2019). Briefly,
Qatar Biobank enrolls adults (age ≥ 18 years), following certain
inclusion/exclusion criteria to obtain a representative sample
of the permanent heterogeneous population that resides in
Qatar. All subjects are Qatari nationals or long-term residents
(≥15 years living in Qatar). Qatari individuals represent 85%
of the total number of QBB participants, while long-term
residents (LTR)-Arabs and LTR-Non-Arabs represent 12% and
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3%, respectively. The mean age of enrolled subjects was
40.5 years (SD± 12).
Genomic Data
Whole-genome sequences of 6,218 Qatari nationals or long-
term residents who had previously participated in Qatar Genome
Programme (QGP) were obtained. Sequencing read data were
previously generated by Illumina HiSeq X Ten1 sequencers and
converted from the native BCL format to paired-end FASTQ2
format using bcl2fastq3. The quality of the raw data was assessed
using fastqc4. Data passing quality control was then aligned to
the reference genome sequence [build GRCh37 (hs37d5)5] using
the bwa-kit6 aligner [v7.12]. Variant calling was performed using
GATK7 haplotype caller [v3.3], and annotation of the resulting
VCF8 was performed using snpeff9 [v4.1b] and the following
databases: dbsnp10 v138 and dbNSFP11 v2.9. The genetic variant
data was then converted to PLINK file format using PLINK-1.9
(Purcell et al., 2007). Standardized quality-assurance and quality
control (QA/QC) methods were followed to generate high quality
and confidence on both SNPs and sample levels, as previously
described (Albagha et al., 2011). Briefly, variants with genotype
call rate < 90%, Hardy-Weinberg p-value < 1 × 10−6 were
removed. Samples with excess heterozygosity (n = 8), duplicates
(n = 10), call rate < 95% (n = 1), gender ambiguity (n = 65), and
population outlier (n = 87) were removed. The final file used for
calculating allele frequency contained 6,047 subjects.
SNPs Data Extraction
Data on SNPs previously linked to SARS-CoV-1 susceptibility
were collected from previous GWAS (Chong et al., 2006;
Chan et al., 2007, 2010; Ng et al., 2007; Lei et al., 2009;
Zhu et al., 2011; Cheng et al., 2015; Patarčić et al., 2015; Tu
et al., 2015). SNPs associated with susceptibility to other viral
infections located in genes significant for SARS disease were
also included in the analysis. Only SNPs that were reported to
have significant associations with viral infections (p-value < 0.05)
were included. For the same set of genes, quantitative trait
loci (eQTLs) were retrieved from eQTLs datasets1,2. Only SNPs
showing robust association with gene expression (association
p-value < 1 × 10−8) were extracted. Subsequently, the effect of
SNPs on gene expression in whole blood was obtained from the
genotype-tissue expression (GTEx) database3.
Data Analysis
PLINK v1.9 was used to prune eQTL SNPs into a list of
independent variants (Purcell et al., 2007). SNPs within a window
of 25 kb and with linkage disequilibrium r2 > 0.5 were pruned
into a single independent SNP using the PLINK command –
indep-pairwise 25 5 0.5. Allele frequencies (AF) between different
populations were compared using the Pearson Chi2 test, with a





A total of 74 SNPs were identified from the literature. These
SNPs are located in 10 genes: ICAM3, IFN-γ, CCL2, CCL5,
AHSG, MBL, Furin, TMPRSS2, IL4, and CD209 promoter.
Table 1 summarizes the list of all SARS-CoV-1 related SNPs
reported by previous GWAS (n = 11) and their potential effect
during infection.
We first compared the frequencies of SARS-CoV-1 related
SNPs in Qatari population genomes (n = 6047) to the global
AFs from the 1000Genome dataset (The International Genome
Sample Resource [IGSR], 2015). In addition, we calculated
the fold difference in the AF in comparison to the Eastern
Asian (EAS) population specifically (n = 504), since all these
susceptibility SNPs were originally identified in the Chinese
population (Figure 1). Analysis of Qatari genomes revealed that
the Qatari population has significantly lower frequency of the
risk alleles in each of: CCL2, MBL, CCL5, AHSG, and IL4 (0.336,
0.099, 0.004, 0.09, and 0.137, respectively), compared to the
1000Genome (0.367, 0.122, 0.025, 0.24, and 0.401, respectively),
as well to the EAS population (0.547, 0.148, 0.095, 0.161, and
0.779, respectively). Remarkably, the most significant difference
was observed in rs2280788 that is located in the CCL5 gene. The
frequency of the risk allele (C) among Qatari population was 6.6-
fold lower than the 1000Genomes (0.372 vs. 2.4%), and 25.6-fold
lower than that of the EAS population (9.52%). Second in line was
rs2070874 in IL4 gene, where the frequency of the risk variant (T)
among Qataris showed around 3-fold decrease (13.7%) compared
to the global AF (40.1%), and a 5.7-fold decrease compared to
EAS population (77.9%). Additionally, the AHSG risk variant
(rs2248690, risk allele = T), was less frequently detected among
Qataris (AF = 0.09), with a 2.7-fold decrease compared to the
EAS population (AF = 0.16). However, although SNPs in CCL2
and MBL genes were significantly different among the Qatari
population, the fold difference was marginal (1 to 2-fold change).
On the other hand, a higher frequency of the risk alleles located
within IFN-γ, ICAM3, Furin, and TMPRSS2 was observed in the
Qatari population (0.517, 0.314, 0.376, and 0.433, respectively),
in comparison to 1000Genomes (0.28, 0.18, 0.264, and 0.396,
respectively), and to the EAS population (0.159, 0.113, 0.16, and
0.36, respectively). Notably, Qatari genomes showed 3.3- and 2.8-
fold increase in the AF of IFN-γ and ICAM3 SNPs compared to
the EAS population. The AF of CD209 variant among Qataris
was comparable to that of 1000Genomes; however, it showed a
3.5-fold decrease in comparison to the EAS population.
We further explored the inter-population variations for each
SNP to identify significant differences (Figure 2). The CCL5 risk
allele (C, rs2280788) was considerably more common among
people from EAS (0.952), reaching to a 32-fold increase compared
to the African and Qatari populations that exhibited the lowest
frequency of this risk allele (0.003 of each population). Similarly,
the percentage of individuals harboring the risk allele (T) in
IL4 (rs2070874) was the highest among EAS population (77.9%)
and the lowest among European population (16.8%). Likewise,
the risk allele (A) of SNP rs4804803 in CD209 promoter, as
well as CCL2 risk variant (G, rs1024611) were significantly
higher among EASs compared to all other populations (93.15%,






















TABLE 1 | Common single nucleotide polymorphisms in host genes related to SARS-CoV-1 infection.










CCL2 17 32579788 rs1024611 G A Upstream gene
variant
SARS-CoV Chinese Increased transcriptional
activity of CCL2- Higher
susceptibility to SARS-CoV-1
Tu et al., 2015
MBL 10 54531235 rs1800450 T C Missense
variant
SARS-CoV Chinese Lower MBL expression- Higher
susceptibility to SARS-CoV-1
Tu et al., 2015
RANTES (CCL5) 17 34207405 rs2280788 C G Upstream gene
variant
SARS-CoV Chinese Higher expression of CCL5
Higher SARS-CoV-1 severity
Ng et al., 2007
AHSG 3 186330088 rs2248690 T A Upstream gene
variant
SARS-CoV Chinese Higher production of AHSG
Lower SARS-CoV-1 severity
Zhu et al., 2011
ICAM3 19 10446568 rs2304237 C T Missense
variant
SARS-CoV Chinese Higher ICAM3 expression-
Higher LDH levels- Higher
SARS-CoV-1 severity
Chan et al., 2007
IFN-γ 12 68552522 rs2430561 A T Intron variant SARS-CoV Chinese Decreased IFN-γ production
Higher SARS-CoV-1 severity
Chong et al., 2006
CD209 promoter 19 7812733 rs4804803 A G Upstream gene
variant
SARS-CoV Chinese Altered CD209 gene expression
Higher LDH levels Poor
SARS-CoV-1 prognosis
Chan et al., 2010




NA Altered IL4 production- Higher
susceptibility to SARS-CoV-1
Patarčić et al., 2015
TMPRSS2 21 42841988 rs2070788 G A Intron variant Influenza Chinese Higher TMPRSS2 expression
Higher susceptibility to influenza
Cheng et al., 2015
42858367 rs383510 T C Intron variant Influenza Chinese Higher TMPRSS2 expression
Higher susceptibility to influenza
Furin 15 91411656 rs4932178 T C Upstream gene
variant
HBV Chinese Higher Furin expression Higher
susceptibility to HBV
Lei et al., 2009
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FIGURE 1 | Fold differences in the risk allelic frequencies of SARS-CoV-1-related SNPs among Qatari population in comparison to 1000Genome and Eastern Asian
populations. The fold change in AF was calculated for each SNP. The significance of AF difference between each two groups was calculated using Pearson Chi2
test. P-value less than 0.05 is flagged with one star (*). P-value less than 0.01 is flagged with two stars (**). P-value less than 0.001 is flagged with three stars (***).
P-value less than 0.0001 is flagged with four stars (****). Ns, not significant. 1000G, 1000Genome project data; EAS, Eastern Asian.
FIGURE 2 | Allelic frequencies of SARS-CoV-1-associated genetic variants among different populations. Representation of population-specific differences in the AFs
of 11 SARS-CoV related SNPs located within 10 genes, in comparison to the overall AF from 1000Genome. AMR, American; AFR, African; QAT, Qatari; SAS, South
Asian; EAS, Eastern Asian; EUR, European. Green and red arrows indicate the effect of each AF on increasing (red) or decreasing (green) susceptibility to
SARS-CoV-1. The number of arrows represents the significance level of difference in AF for each population compared to the 1000Genome. P-value less than 0.05
is flagged with one arrow (1). P-value less than 0.01 is flagged with two arrows (11). P-value less than 0.0001 is flagged with three arrows (111).
and 54.66%, respectively), while the Africans had the lowest
percentages of both mutations (55.52% and 22.77%, respectively).
Africans showed an extremely lower AF of MBL risk variant
(T, rs1800450, AF = 0.013), which is 9-folds less than the
global AF (0.122), while Americans presented the highest AF
(0.219). Likewise, the frequency of the risk allele (G) of TMPRSS2
rs2070788 was the lowest among Africans (0.2738), and the
highest in Americans (0.4942). However, the other SNP that
also affects TMPRSS2 expression (rs383510) was more frequent
among European population (0.4851), while African population
also exhibited the lowest frequency (0.3268). The distribution
of the T risk allele of AHSG gene was similarly high among
Africans and Americans (0.2784 and 0.3646, respectively), but
less detected among Qatari population (9%). Qatari individuals,
on the other hand, showed the highest AF in risk variants of Furin
(T, rs4932178, 0.3763), ICAM3 (C, rs2304237, 0.3141), and IFN-γ
(A, rs2430561, 0.5167) in comparison to all other populations.
Lastly, for the same set of genes, we investigated the genetic
variations that were already annotated as eQTLs in the whole
blood, which might affect disease susceptibility or severity.
We also used QGP dataset and as well as data deposited in
1000Genome for the analysis. Only four out of ten genes had
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significant associations in the eQTL databases: CCL5, CD209,
ICAM3, and MBL, where 63 eQTLs were located (Supplementary
Table S1). Of these, only ten variants were found to be
independent SNPs and were further investigated. Table 2
demonstrates the eQTLs included in the analysis and their
suggested effect on gene expression. Our analysis showed that the
frequency of almost all these eQTL variants differs considerably
between populations. Mainly, African ancestry has up to 4-fold
decrease in the frequency of eQTLs in CD209 (rs10518270), and
ICAM3 (rs3181049 and rs3176767). The European population,
on the other hand, had the lowest frequency of rs4239252 in
CCL5 (2.4-fold difference). Of note, other eQTLs appear to vary
between populations, yet, with a lower fold difference (Table 3).
DISCUSSION
Since the start of the current SARS-CoV-2 pandemic, scientists
have been puzzling over the factors underlying the inter-
individual and inter-population differences in disease outcomes.
The resulting clinical manifestation of COVID-19 varied
enormously, ranging from mild/asymptomatic illness in 80%
of patients to a severe respiratory syndrome in 20%, which
further progresses to critical illness requiring ventilation in
5% (CDC, 2020). In addition, the mortality rates were
interestingly different between countries. As of August 5, 2020,
the highest mortality rate was seen in European countries
such as in the United Kingdom, Italy, and France, reaching
15% (Statistica, 2020). On the contrary, the lowest rate of
death from COVID-19 was reported from several Western
and South Asian countries such as Singapore (0.06%), Qatar
(0.1%), and Bahrain (0.27%) and African countries such
as Rwanda (0.24%) and Uganda (0.42%) (Statistica, 2020).
These figures are affected by several factors, including the
testing capacity in each country, the age and health status
of individuals, the efficiency of the health system, and the
possible circulation of different viral strains. However, population
genetics can also be a key factor. The earlier SARS-CoV-
1 outbreak in 2003 had shed some light on the host
genetic contribution in disease manifestations and outcomes.
A number of GWASs have identified genetic markers with
associations with SARS-CoV-1, yet, all were conducted on
Chinese population, where SARS-CoV-1 originated and mainly
circulated. Nevertheless, to the best of our knowledge, the
prevalence and frequency of these variants have never analyzed
in comparison to other populations, including the Middle
East and North Africa (MENA) population. Accordingly,
in this report, we performed a comparative analysis on a
TABLE 2 | Independent eQTL variants in host genes related to SARS-CoV-1 infection.
Gene CHR Position SNP ID Minor/Major allele Risk allele Consequence SNP effect on gene expression P-value
CCL5 17 34163565 rs4239252 A/G A Intron variant Downregulation 2 × 10−7
CD209 19 7781435 rs10518270 G/A G Intergenic variant Downregulation 2.9 × 10−4
7785713 rs2335525 G/A G Regulatory region variant Downregulation 8.8 × 10−4
7807610 rs4804802 A/G G Downstream gene variant Downregulation 0.1
ICAM3 19 10441117 rs3181049 A/G A Downstream gene variant Downregulation 1.8 × 10−3
10449751 rs3176767 G/T G Intron variant Downregulation 6 × 10−4
10457917 rs4611572 C/G G Downstream gene variant Downregulation 3.7 × 10−8
10446734 rs281413 A/G A Intron variant NA –
10449392 rs2304240 A/G G Synonymous variant Downregulation 1.6 × 10−17
MBL 10 54531685 rs7096206 G/C C Upstream gene variant NA –
NA, Data not available; CHR, chromosome number; 1000G, 1000Genome project data; QAT, Qatari; AFR, African; AMR, American; EAS, Eastern Asian; EUR, European;
SAS, South Asian.
TABLE 3 | Allelic frequency of eQTL in genes related to SARS-CoV-1 infection.
Gene SNP ID Minor/Major allele Risk allele Minor allele frequency
1000G QAT AFR AMR EAS EUR SAS
CCL5 rs4239252 A/G A 0.39600 0.22780 0.60670 0.28820 0.45630 0.16200 0.36610
CD209 rs10518270 G/A G 0.18910 0.24860 0.04390 0.09510 0.31150 0.14020 0.37630
rs2335525 G/A G 0.40590 0.41350 0.68000 0.18590 0.32540 0.26240 0.42230
rs4804802 A/G G 0.21630 0.13970 0.33360 0.09650 0.31450 0.11430 0.14620
ICAM3 rs3181049 A/G A 0.12520 0.28359 0.03780 0.15850 0.08230 0.21470 0.17180
rs3176767 G/T G 0.17930 0.31690 0.13920 0.17440 0.11410 0.23560 0.24640
rs4611572 C/G G 0.47700 0.48540 0.62030 0.51440 0.34230 0.42150 0.45300
rs281413 A/G A 0.16830 0.12980 0.23150 0.14410 0.08530 0.19580 0.15750
rs2304240 A/G G 0.17170 0.11998 0.06280 0.33290 0.17460 0.17690 0.19630
MBL rs7096206 G/C G 0.19550 0.28450 0.15360 0.13110 0.18550 0.22070 0.28220
1000G, 1000Genome project data; QAT, Qatari; AFR, African; AMR, American; EAS, Eastern Asian; EUR, European; SAS, South Asian.
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set of genetic polymorphisms that could have a potential
effect on SARS-CoV-2 susceptibility or severity, utilizing the
datasets from Qatar Genome Programme (QGP), as well as
the 1000Genomes.
Initially, we looked at the overall burden of risk variants
associated with SARS-CoV-1 in the Qatari population. These
variants are mostly located in genes involved in viral entry
(TMPRSS2 and Furin), cytokine production (IFN-γ and IL4),
and immune responses (ICAM3, CCL2, CCL5, AHSG, MBL,
and CD209). Our analysis showed a remarkable decrease in the
risk allelic frequencies of SNPs linked to SARS severity in the
Qatari population, such as IL4, AHSG, CCL5, and CCL2 variants.
However, the Qatari population had a significantly higher
frequency of SNPs related to increased disease susceptibility,
including TMPRSS2, Furin, and IFN-γ variants. The only
genetic polymorphism associated with SARS-CoV-1 severity
and found at a higher rate among Qataris is the ICAM3
gene polymorphism (rs2304237). This variant was previously
reported to upregulate ICAM3 gene expression and increase
SARS-CoV-1 severity. Nonetheless, two eQTLs in the same
gene (rs3181049 and rs3176767), which are responsible for
downregulating ICAM3 expression and potentially decreasing
SARS-CoV-1 severity, were detected at the highest rate among
Qataris. These findings align with the current situation in
Qatar, where high rates of SARS-CoV-2 infections are reported
despite the low severity (ICU cases = 1%), and mortality
rates (0.1%) (Ministry of Public Health [MOPH], 2020).
Although this data mostly represent the disease spread among
expatriates who represent 85% of Qatar population, Qatari
citizens also have extremely low fatality rates (0.07%, personal
communication, June 2020).
Investigating the differences in the distribution of SARS-CoV-
1 associated SNPs and eQTLs in different populations showed
great diversity. The fold difference in AFs between populations
reached up to 32-fold change as observed in rs2280788 (CCL5
gene) which was found in 9.5% of EAS population compared to
0.3% only among Africans and Qataris. Similarly, rs1800450 in
the MBL gene showed a high variability between populations (16-
fold difference). This variant was found in 22% of Americans
compared to only 1.36% of Africans. This data highlights again
the importance of explaining infections spread and pathogenesis
in the light of population genetics. Noticeably, the European
population showed an opposite fold direction in the allelic
frequency of most SNPs compared to the African and EAS
propulsions. In other words, all risk variants, which were more
commonly detected in Europeans (TMPRSS2, Furin, ICAM3, and
IFN-γ), were significantly lower among Africans and EASs. In
fact, compared to all other populations, African descent seems
to carry substantially lower frequencies of the risk alleles in most
SNPs (8 out of 11 SNPs). Previous population genetics studies
pointed out the great differences in the amplitude of the immune
response between Africans and Europeans, especially in genes
related to inflammatory and antiviral responses (Quach et al.,
2016). In agreement with our findings, a recent study also showed
that African have a genetic predisposition for lower expression
levels of both ACE2 and TMPRSS2 genes, which are key viral
entry genes in SARS-CoV-2 infection (Ortiz-Fernández and
Sawalha, 2020). Collectively, this could explain the population
differences in COVID-19 infection and fatality rates. Africa
is still considered an outlier in terms of COVID-19 spread.
The number of cases in Africa (as of August 5, 2020) is the
lowest (981,593 positive cases), compared to other continents
(3–5 million positive cases) (Worldometers, 2020). Additionally,
despite their fragile health system, Africans are still reporting
a relatively low mortality rate (2.2%), compared to the global
death rate, which is 3.7% (Worldometers, 2020). Nonetheless, it
is worth mentioning that the limited testing capacity in African
countries could largely underestimate the actual burden. To the
contrary, it has been reported that the death rate from COVID-
19 is 6-fold higher among African Americans counties compared
to predominantly white counties (Yancy, 2020). Whether this
observation is solely related to socioeconomic and cultural factors
or also affected by genetic factors, require further investigation.
Although SARS-CoV-1 and SARS-CoV-2 were originally
identified in EAS (China), our analysis revealed that only three
susceptibility loci were significantly higher among the EASs
(IL4, CD209 promoter, and CCL2). This could be attributed
to the limited set of variants included in our analysis and
does not exclude the possibility of the EAS population being
differently vulnerable to coronaviruses. A recent study reported
that EAS individuals have higher allele frequencies in the eQTL
variants associated with augmented ACE2 expression in tissues,
suggesting a possible different susceptibility or response to SARS-
CoV-2 (Cao et al., 2020). Nonetheless, additional well-designed
studies, larger in size and scope, are needed to better characterize
the population differences in SARS-CoV2 susceptibility and
disease outcomes.
One of the main clinical features of severe COVID-19 is
the exacerbated inflammatory response. Both SARS-CoV-1 and
SARS-CoV-2 infections are known to induce a massive over-
release of cytokines, which contributes to infection pathogenesis
and severity. SARS-CoV-infected cells produce high levels of
chemokines, including CCL2, and CCL5, and proinflammatory
cytokines such as IFN-γ (Chang et al., 2020). We found that
variants, which increase the expression of these molecules
specifically, are distributed differently among populations, and
consequently, will differ between individuals. These variants
could be useful as prognostic markers to stratify patients and
identify high-risk individuals.
In conclusion, we highlight here the population-dependent
variations in genes potentially influencing SARS-CoV-2
infection. Results from this work emphasize the importance
of understanding the interplay between host genetic factors
and response to infections, which could have important
implications on public health infections control and therapeutics.
Importantly, results presented here provide preliminary insights
that necessitate functional validation in future studies.
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